Makana Therapeutics Team

Joe Tector, MD, PhD, FACS

Joe Tector, MD, PhD, FACS

Founder

More than 30 years of experience in transplant surgery and as Director, Xenotransplant Institute; Surgical Director, Small Bowel and Multivisceral Transplant Program, University of Miami Medical School. Dr. Tector received his training from McGill University, University of Miami, and St Louis University School of Medicine.
Mark Platt

Mark Platt

President & CEO

Platt has 34 years of experience in business and organizational leadership with strong background in manufacturing, engineering, hospital administration, sales, marketing and product development. Former Pres/CEO of Multistack, SVP at Gundersen Health System, Gundersen Board of Trustees, Combat Engineering Officer-U.S. Air Force Reserve. B.S. – Electrical Engineering and Mathematics, Vanderbilt University.
Matt Tector, PhD

Matt Tector, PhD

Chief Scientific Officer

Prior to joining Makana oversaw the creation and validation of the TKO pig and xenotransplant-related histocompatibility assays.
Ed Gray

Ed Gray

Chief Operating Officer

Transplantation industry veteran with broad experience in genetic engineering, porcine development and facilities, infection disease, preclinical program design and execution, regulatory strategy and planning.
Rocco Morelli

Rocco Morelli

Chief Commercial Officer and Interim CEO at Recombinetics

Morelli has 30 years of commercial and operational leadership experience in medical device, biotech and healthcare with strong background in business development, licensing, M&A with commercial strategy and market development.
Dan Carlson, PhD

Dan Carlson, PhD

Chief Scientific Officer, Recombinetics

Carlson has been with RCI since inception and is named on most of RCI’s 300+ patent applications. Dan is a recognized leader in large animal genetic engineering, advanced reproduction, and animal husbandry.
Adrienne Watson, PhD

Adrienne Watson, PhD

VP, Research & Development

Watson joined RCI in 2013, where she has led the development of swine models for preclinical drug and device studies and regenerative therapeutics.
David Aberle, MBA

David Aberle, MBA

Chief Financial Officer

Aberle has 20 years experience in financial management and was the CFO at AGA Medical Corp. (Acquired by St. Jude Medical).
John Burtis, JD

John Burtis, JD

Vice President, Legal

Burtis has 20 years of experience representing clients in complex transactional, corporate, litigation and intellectual property legal matters.